BioSyent Inc. (CVE:RX – Get Free Report) insider FAX Capital Corp. sold 500,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of C$10.05, for a total transaction of C$5,025,000.00.
BioSyent Trading Up 0.5 %
Shares of RX opened at C$10.90 on Wednesday. The stock has a market capitalization of C$126.33 million, a P/E ratio of 18.17 and a beta of 0.94. BioSyent Inc. has a twelve month low of C$7.66 and a twelve month high of C$11.45. The company has a quick ratio of 6.91, a current ratio of 6.13 and a debt-to-equity ratio of 3.40. The firm has a fifty day simple moving average of C$10.16 and a two-hundred day simple moving average of C$9.29.
BioSyent Company Profile
Featured Articles
- Five stocks we like better than BioSyent
- Election Stocks: How Elections Affect the Stock Market
- 3 Small Cap Stocks That Insiders Are Buying
- What is the Hang Seng index?
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- Stock Sentiment Analysis: How it Works
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.